黑色素瘤手术延迟与保险类型相关
该回顾性队列研究纳入2004至2011年北卡罗来纳州7629例0至III期黑色素瘤患者,分析诊断至手术延迟(超过6周)与保险类型的关系。结果显示Medicaid患者手术延迟风险显著高于私人保险(RR 1.36),由皮肤科医生诊断或手术者延迟风险更低。
要点
- Medicaid患者黑色素瘤手术延迟风险较私人保险高36%(RR 1.36)。
- 皮肤科医生参与诊断或手术可降低手术延迟风险(RR 0.81和0.82)。
- 非白人患者手术延迟风险更高(RR 1.38)。
核心结论
- 黑色素瘤手术延迟常见,Medicaid患者延迟风险最高,皮肤科医生参与可降低延迟风险。
研究设计与样本
- 回顾性队列研究,纳入2004至2011年北卡罗来纳州癌症登记库中0至III期黑色素瘤患者7629例,链接Medicare、Medicaid和私人保险理赔数据。
- 纳入标准为连续参保至少从诊断前1个月至诊断后12个月。
主要发现
- 手术延迟(诊断后超过6周行确定性切除)发生率:私人保险14%(519例),Medicare 17%(609例),Medicaid 24%(79例),P < .001。
- 人口学调整后,Medicaid相比私人保险的手术延迟风险比RR为1.36(95% CI 1.09-1.70)。
- 非白人患者手术延迟风险比RR为1.38(95% CI 1.02-1.87)。
- 手术医生为皮肤科医生相比非皮肤科医生,延迟风险比RR为0.82(95% CI 0.72-0.93)。
- 诊断医生为皮肤科医生相比非皮肤科医生,延迟风险比RR为0.81(95% CI 0.71-0.93)。
临床怎么用
- 临床应关注Medicaid和非白人黑色素瘤患者的手术延迟风险,优化专科转诊和跨学科协调。
- 皮肤科医生参与诊断或手术可能减少手术延迟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Timely receipt of treatment for cancer is an important aspect of health care quality. It is unknown how delays of surgery for melanoma vary by insurance type. OBJECTIVE: To analyze factors associated with delays between diagnosis and surgery for melanoma in patients with Medicare, Medicaid, or private insurance. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of patients who received a diagnosis of melanoma between 2004 and 2011 in North Carolina using data from the North Carolina Cancer Registry linked to administrative claims from Medicare, Medicaid, and private insurance. Inclusion criteria were incident patients with a diagnosis of melanoma stage 0 to III and with continuous insurance enrollment from at least 1 month prior to the month of diagnosis to 12 months after diagnosis of melanoma. MAIN OUTCOMES AND MEASURES: Surgical delay, defined as definitive surgical excision occurring more than 6 weeks after melanoma diagnosis. Generalized linear models with log link, Poisson distributions, and robust standard errors were used to estimate adjusted risk ratios (RRs) to model risk of delay in definitive surgery. RESULTS: A total of 7629 patients were included (4210 [55%] female; mean [SD] age, 64 [15] years), 48% (n = 3631) Medicare, 48% (n = 3667) privately insured, and 4% (n = 331) Medicaid patients. Privately insured patients were least likely to experience a delay in definitive surgery, followed by Medicare and Medicaid patients (519 [14%], 609 [17%], and 79 [24%], respectively; P < .001). After demographic adjustment, the risk of surgical delay was significantly increased in patients with Medicaid compared with private insurance (RR, 1.36; 95% CI, 1.09-1.70). Delays were more likely in nonwhite patients (RR, 1.38; 95% CI, 1.02-1.87). Surgical delays were less likely if the physician performing the surgery (RR, 0.82; 95% CI, 0.72-0.93) or the diagnosing clinician (RR, 0.81; 95% CI, 0.71-0.93) was a dermatologist as compared with a nondermatologist. CONCLUSION AND RELEVANCE: Surgical treatment delays were common but were less prevalent in patients diagnosed or surgically treated by a dermatologist. Medicaid patients experienced the most surgical delays. A reduction in delays in melanoma surgery could be achieved through better access to specialty care and cross-disciplinary coordination.
引用
- Adamson AS, Zhou L, Baggett CD, et al. Association of Delays in Surgery for Melanoma With Insurance Type. JAMA Dermatol. 2017. PMID: 28979974. doi:10.1001/jamadermatol.2017.3338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。